Power to methane:WP7: communication

This Workpackage designs and implements ways of communication on the progress and results of the Power to Methane project to the outside world by means of target group differentiation, communication plan, design of an appropriate project logo and overall incentive to tell the world what we are doing, how and why

Le monument funéraire néolithique de Poses « Sur la Mare » (Eure)

La fouille d’une large surface, à Poses, au lieu-dit « Sur la Mare », a permis d’étudier les vestiges d’une petite structure funéraire en partie arasée. Cet édifice est constitué d’une couronne d’empierrement en blocs de craie, de forme ovalaire et délimitant un espace central quadrangulaire d’environ 4 m sur 6. Cet espace intérieur, légèrement excavé, a fourni d’une part une structure contenant un vase, et d’autre part une nappe d’ossements brûlés associés à d’autres restes également brûlés : fragments de céramique, outillages osseux et lithique. Les questions concernant le type de fonctionnement, l’architecture et la datation de cet édifice à une phase de transition entre les Néolithiques moyen et récent font ici l’objet d’une discussion.Area excavation at Poses “Sur la Mare” revealed a small Neolithic burial structure. This partly eroded monument consisted of an oval surround of chalk blocks, defining a central quadrangular area 4 by 6 metres. This space, slightly hollowed, had in one section a feature containing a pot, in another section a deposit of cremated bones associated with other burnt material: shards, worked bone and flints. Discussion centres on the function, the architecture and the dating of this structure in a transitional phase between the middle and late Neolithic

CubeSpec, A Mission Overview

CubeSpec is an in-orbit demonstration CubeSat mission in the ESA technology programme, developed and funded in Belgium. The goal of the mission is to demonstrate high-spectral-resolution astronomical spectroscopy from a 6-unit CubeSat. The prime science demonstration case for the in-orbit demonstration mission is to unravel the interior of massive stars using asteroseismology by high-cadance monitoring of the variations in spectral line profiles during a few months. The technological challenges are numerous. The 10x20cm aperture telescope and echelle spectrometer have been designed to fit in a 10x10x20cm volume. Under low-Earth orbit thermal variations, maintaining the fast telescope focus and spectrometer alignment is achieved via an athermal design. Straylight rejection and thermal shielding from the Sun and Earth infrared flux is achieved via deploying Earth and Sunshades. The narrow spectrometer slit requires arcsecond-level pointing stability using a performant 3-axis wheel stabilised attitude control system with star tracker augmented with a fine beam steering mechanism controlled in closed loop with a guiding sensor. The high cadence, long-term monitoring requirement of the mission poses specific requirements on the orbit and operational scenarios to enable the required sky visibility. CubeSpec is starting the implementation phase, with a planned launch early 2024

Neonatal screening for congenital hypothyroidism in the Netherlands: Cognitive and motor outcome at 10 years of age

Contains fulltext : 35300.pdf (publisher's version ) (Open Access)CONTEXT: Patients with thyroidal congenital hypothyroidism (CH-T) born in The Netherlands in 1981-1982 showed persistent intellectual and motor deficits during childhood and adulthood, despite initiation of T(4) supplementation at a median age of 28 d after birth. OBJECTIVE: The present study examined whether advancement of treatment initiation to 20 d had resulted in improved cognitive and motor outcome. DESIGN/SETTING/PATIENTS: In 82 Dutch CH-T patients, born in 1992 to 1993 and treated at a median age of 20 d (mean, 22 d; range, 2-73 d), cognitive and motor outcome was assessed (mean age, 10.5 yr; range, 9.6-11.4 yr). Severity of CH-T was classified according to pretreatment free T(4) concentration. MAIN OUTCOME MEASURE: Cognitive and motor outcome of the 1992-1993 cohort in comparison to the 1981 to 1982 cohort was the main outcome measure. RESULTS: Patients with severe CH-T had lower full-scale (93.7), verbal (94.9), and performance (93.9) IQ scores than the normative population (P < 0.05), whereas IQ scores of patients with moderate and mild CH-T were comparable to those of the normative population. In all three severity subgroups, significant motor problems were observed, most pronounced in the severe CH-T group. No correlations were found between starting day of treatment and IQ or motor outcome. CONCLUSIONS: Essentially, findings from the 1992-1993 cohort were similar to those of the 1981-1982 cohort. Apparently, advancing initiation of T(4) supplementation from 28 to 20 d after birth did not result in improved cognitive or motor outcome in CH-T patients

Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility

Epidemiological and genetic studies on COVID-19 are currently hindered by inconsistent and limited testing policies to confirm SARS-CoV-2 infection. Recently, it was shown that it is possible to predict COVID-19 cases using cross-sectional self-reported disease-related symptoms. Here, we demonstrate that this COVID-19 prediction model has reasonable and consistent performance across multiple independent cohorts and that our attempt to improve upon this model did not result in improved predictions. Using the existing COVID-19 prediction model, we then conducted a GWAS on the predicted phenotype using a total of 1,865 predicted cases and 29,174 controls. While we did not find any common, large-effect variants that reached genome-wide significance, we do observe suggestive genetic associations at two SNPs (rs11844522, p = 1.9x10-7; rs5798227, p = 2.2x10-7). Explorative analyses furthermore suggest that genetic variants associated with other viral infectious diseases do not overlap with COVID-19 susceptibility and that severity of COVID-19 may have a different genetic architecture compared to COVID-19 susceptibility. This study represents a first effort that uses a symptom-based predicted phenotype as a proxy for COVID-19 in our pursuit of understanding the genetic susceptibility of the disease. We conclude that the inclusion of symptom-based predicted cases could be a useful strategy in a scenario of limited testing, either during the current COVID-19 pandemic or any future viral outbreak

Further evidence of the involvement of the Wnt signaling pathway in Dupuytren’s disease

Genetic background plays an important role in the development of Dupuytren's disease. A genome-wide association study (GWAS) showed that nine loci are associated with the disease, six of which contain genes that are involved in Wnt signaling (WNT2, WNT4, WNT7B, RSPO2, SFRP4, SULF1). To obtain insight in the role of these genes, we performed expression studies on affected and unaffected patient's tissues. Surgically obtained nodules and cords from eight Dupuytren's patients were compared to patient-matched control tissue (unaffected transverse palmar fascia). The Wnt-related genes found in the GWAS, the classical Wnt-downstream protein beta-catenin, as well as (myo) fibroblast markers were analyzed using real-time qPCR and immunohistochemical stainings for mRNA levels and protein levels, respectively. The collagen-coding genes COL1A1 and COL3A1 were highly upregulated on mRNA level, both in cords and nodules. Three Wnt-related genes were found to be differently regulated compared to control tissue: WNT2 was downregulated in nodules, WNT7B was upregulated in nodules, and SFRP4 was upregulated in nodules and cords. Immunohistochemistry revealed significantly less staining of Wnt2 in cords, but significantly more staining for Wnt7b in nodules. There was significantly more staining of alpha-SMA in nodules and cord and beta-catenin in nodules than in control tissue. We found differences in expression, both at mRNA and protein level, in several Wnt-related genes found earlier to be associated with Dupuytren's disease. Of these, Wnt7b was upregulated and found in close association with both alpha-SMA and beta-catenin expressing cells, making it a candidate pro-fibrotic mediator in Dupuytren's disease

SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

Variability in SARS-CoV-2 susceptibility and COVID-19 disease severity between individuals is partly due to genetic factors. Here, we identify 4 genomic loci with suggestive associations for SARS-CoV-2 susceptibility and 19 for COVID-19 disease severity. Four of these 23 loci likely have an ethnicity-specific component. Genome-wide association study (GWAS) signals in 11 loci colocalize with expression quantitative trait loci (eQTLs) associated with the expression of 20 genes in 62 tissues/cell types (range: 1:43 tissues/gene), including lung, brain, heart, muscle, and skin as well as the digestive system and immune system. We perform genetic fine mapping to compute 99% credible SNP sets, which identify 10 GWAS loci that have eight or fewer SNPs in the credible set, including three loci with one single likely causal SNP. Our study suggests that the diverse symptoms and disease severity of COVID-19 observed between individuals is associated with variants across the genome, affecting gene expression levels in a wide variety of tissue types

A first update on mapping the human genetic architecture of COVID-19

peer reviewe